Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...

Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.50 per share, payable on September 15, 2025, to shareholders of record as of the close of ...

Albertans are missing credit payments at one of the highest rates in the country, as Equifax Canada warns of a widening ...

The study aims to assess the safety and efficacy of Efruxifermin (EFX) in treating patients with NASH/MASH and fibrosis, a significant health concern due to its potential to progress to cirrhosis and ...

SingleKey, a leading provider of residential leasing solutions, has expanded their relationship with Equifax® Canada to ...

Anyone who's teed it up at The Meadow at Peabody golf course would certainly vouch for its daunting layout and overall ...

The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Quality boots, weather systems, and field accessories were among the highlights of this year's product launches. Here’s what ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high ...

Shares of Equifax Inc. EFX slid 2.06% to $248.07 Thursday, on what proved to be an all-around mixed trading session for the ...